Who is sponsoring NCT01880554?

NCT01880554 is sponsored by Institut Bergonié.

What drugs are being tested in NCT01880554?

Interventions in NCT01880554: Contrast-enhanced intraoperative ultrasound.

What condition does NCT01880554 study?

NCT01880554 studies Liver Metastases From Colorectal Primary Cancer.

Is NCT01880554 still recruiting?

NCT01880554 is currently completed. Last updated 22 August 2025.

Are results published for NCT01880554?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-08-22 · How we verify

NCT01880554: ULIIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Utility of Contrast-enhanced Intraoperative Ultrasound in Surgery of Colorectal Liver Metastases. Phase II Clinical Trial.

Completed NA Results posted Last updated 22 August 2025

What this trial tests

NA trial testing Contrast-enhanced intraoperative ultrasound in Liver Metastases From Colorectal Primary Cancer in 68 participants. Completed in 1 June 2017.

Timeline

1 June 2011

Primary endpoint
1 September 2016

1 June 2017

Quick facts

Lead sponsor	Institut Bergonié
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	68
Start date	1 June 2011
Primary completion	1 September 2016
Estimated completion	1 June 2017
Sites	1 location across France

Drugs / interventions tested

Contrast-enhanced intraoperative ultrasound

Conditions studied

Liver Metastases From Colorectal Primary Cancer — all drugs for Liver Metastases From Colorectal Primary Cancer →

Sponsor

Institut Bergonié — full company profile →

Who can join

18 and older, any sex, with Liver Metastases From Colorectal Primary Cancer. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Clinical Utility of Intraoperative Contrast Ultrasound in the Surgery of Colorectal Cancer Liver Metastases.
Time frame: At time of surgery
The clinical utility will be evaluated in terms of justified modification of the surgical procedure following contrast-enhanced intra-operative ultrasound (CE-IOUS), compared to the surgical procedure following conventional intra-operative ultrasound. For each patient, we will consider CE-IOUS to be clinically useful: * if the surgical procedure envisaged at the end of the CE-IOUS is different fr

Sponsor's own description

Hypothesis: Use of contrast ultrasound showed interesting results, which can increase ultrasonography sensitivity performed during surgery in the evaluation of operable liver metastases. This study is a two-stage phase II multicenter study (Simon's two-stage).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Contrast-enhanced intra-operative ultrasound as a clinical decision making tool during surgery for colorectal liver metastases: The ULIIS study.
Desolneux G, Isambert M, Mathoulin-Pelissier S, Dupré A, et al · · 2019 · cited 8× · PMID 30879929 · DOI 10.1016/j.ejso.2019.03.002

Verify or expand the search:

Other Institut Bergonié trials

Trials by the same sponsor.

NCT06084689 — Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures · Phase 2 · withdrawn
NCT06700057 — Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer. · recruiting
NCT05690828 — Evaluation of Cognitive Management for Chemobrain in Patients Treated for Breast Cancer. · NA · active not recruiting
NCT05415527 — Evaluation of Pretreatment Sarcopenia in Patients With Inoperable High-grade Ovarian Carcinoma as Part of Optimised Mana · NA · active not recruiting
NCT04912687 — Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01880554 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Bergonié
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01880554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing